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Background:

•

https://doi.org/10.1148/radiol.2021210591

•

Content codes:

Lack of standardization in CT protocol choice contributes to radiation dose variation.

Purpose: To create a framework to assess radiation doses within broad CT categories defined according to body region and clinical
imaging indication and to cluster indications according to the dose required for sufficient image quality.

This was a retrospective study using Digital Imaging and Communications in Medicine metadata. CT examinations in adults from January 1, 2016 to December 31, 2019 from the University of California San Francisco International CT
Dose Registry were grouped into 19 categories according to body region and required radiation dose levels. Five body regions had a
single dose range (ie, extremities, neck, thoracolumbar spine, combined chest and abdomen, and combined thoracolumbar spine).
Five additional regions were subdivided according to dose. Head, chest, cardiac, and abdomen each had low, routine, and high
dose categories; combined head and neck had routine and high dose categories. For each category, the median and 75th percentile
(ie, diagnostic reference level [DRL]) were determined for dose-length product, and the variation in dose within categories versus
across categories was calculated and compared using an analysis of variance. Relative median and DRL (95% CI) doses comparing
high dose versus low dose categories were calculated.

Materials and Methods:

Results: Among 4.5 million examinations, the median and DRL doses varied approximately 10 times between categories compared
with between indications within categories. For head, chest, abdomen, and cardiac (3 266 546 examinations [72%]), the relative
median doses were higher in examinations assigned to the high dose categories than in examinations assigned to the low dose categories, suggesting the assignment of indications to the broad categories is valid (head, 3.4-fold higher [95% CI: 3.4, 3.5]; chest,
9.6 [95% CI: 9.3, 10.0]; abdomen, 2.4 [95% CI: 2.4, 2.5]; and cardiac, 18.1 [95% CI: 17.7, 18.6]). Results were similar for DRL
doses (all P , .001).

Broad categories based on image quality requirements are a suitable framework for simplifying radiation dose assessment,
according to expected variation between and within categories.

Conclusion:

© RSNA, 2021

R

adiation doses for CT are highly variable across patients and institutions (1). Although some of this
variation reflects hardware characteristics and appropriate differences because of patient factors such as size and
clinical indication for imaging, most of the variation
stems from provider choices in how CT is performed (2).
The protocols used in CT are not standardized according to clinical indications across locations or even among
providers within the same location. Thus, protocol decisions affect considerably the amount of radiation patients
receive during CT scanning (2,3). Radiologists, medical

physicists, and professional organizations have made considerable efforts to standardize protocols (4–8), yet large
variations in radiation dose persist (2,9).
Excessive radiation from undergoing multiple or higherdose CT examinations may be associated with increased
cancer risk (10,11); thus, reducing radiation whenever possible is beneficial to the patient. Because the amount of
radiation needed for adequate image quality varies according to anatomic region and clinical indication, what constitutes an excessive radiation dose will also vary according
to anatomic region and clinical indication.

This copy is for personal use only. To order printed copies, contact reprints@rsna.org
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Abbreviations
CTDIvol = volume CT dose index, DLP = dose-length product, DRL =
diagnostic reference level

Summary
A framework that assigns CT examinations into broad categories based
on body region and image quality requirements simplifies assessment
of radiation dose for benchmarking and for developing CT protocols.

Key Results
N

N

N

Based on 4.5 million CT examinations grouped into 19 categories
according to body region and expected image quality requirements, radiation doses varied approximately 10 times between
categories compared with between indications within categories
(P , .001), meaning the categories are valid.
Radiation doses were significantly higher for examinations assigned to the high versus low radiation dose category; for example,
3.4-fold higher for head; 9.6 for chest; 18.1 for cardiac; and 2.4
for abdomen.
Approximately 91% (4 129 165 examinations) of diagnostic CT
examinations can be assigned to one of the 19 categories; three
categories—routine head, routine chest, and routine abdomen—
account for 67% (2 796 365 examinations) of total examinations.

One approach to aid in the selection and assessment of CT
radiation doses is the publication of benchmarks that clinicians
can use when making local choices for how to scan patients.
The most commonly used benchmarks are created according to
protocol, such as single-phase and multiple-phase abdomen CT
(1). The primary challenge in using a protocol-based approach
for setting benchmarks is that there is little consensus or consistency in how patients are assigned to protocol. Therefore, assessing radiation doses at a facility using only information from
protocols can lead to misleading results, as protocol choice is
at the discretion of the radiologist and is a key determinant of
quality. Stratifying according to that choice eliminates the ability
to form a judgment about this important component of quality.
Furthermore, imaging facilities often create customized sets of
protocols, and the idiosyncratic nature of such protocols makes
comparisons difficult across sites.
To simplify evaluation of radiation doses, we developed a
framework that assigns CT examinations into 19 broad categories based on body region and clinical indication, where we
grouped indications that have similar image quality requirements into the same category. These 19 categories capture the
vast majority of reasons why patients undergo CT, and the use
of these categories can aid in benchmarking. We used data from
a large CT registry to assess the content validity of our approach
by examining actual radiation doses within and across categories.

Materials and Methods
Registry and Collaborating Institutions
The University of California San Francisco International CT
Dose Registry includes CT examination data captured from 161
hospitals or imaging facilities across seven countries. The registry is smaller than, but broadly similar to, the larger American
College of Radiology Dose Index Registry (12). Although both
registries focus on dose optimization, a defining purpose of the
2

University of California San Francisco registry has been to assess
radiation dose delivered across a global range of facilities and
to use these data to develop and study the impact of interventions to improve the safety of CT. The data are captured in a
manner compliant with the Health Insurance Portability and
Accountability Act using dose management software (Radimetrics, Bayer) and have been used previously to describe factors
associated with radiation dose levels, in the context of a randomized controlled trial (2,13). The institutional review boards at the
lead and collaborating institutions approved the study, relied on
the lead institution’s approval, or considered the study exempt
human subjects research.
Study Population
Drawing from the registry, we retrospectively analyzed consecutive diagnostic CT examinations performed from January
1, 2016, to December 31, 2019, in patients aged 18 years and
older. Data were derived from 383 scanners, including 74 models from the four largest manufacturers—GE Healthcare, Philips,
Siemens, and Canon Medical Systems.
Image Quality–informed Framework for CT Categories
Because different parts of the body require different amounts
of radiation to create images sufficient for diagnosis, the framework first relies on categorizing CT examinations into 10 body
regions. In five of these regions (ie, extremities, neck [which
includes cervical spine], thoracolumbar spine [reflecting either
thoracic spine or lumbar spine], combined chest and abdomen,
and combined thoracolumbar spine [reflecting both thoracic
and lumber spine]), clinical indications for scanning do not play
a substantial role in altering the amount of radiation needed;
thus, there is a single category for each of these body regions. In
five other body regions (ie, head, chest, cardiac, abdomen, and
combined head and neck), clinical indications affect the optimal
radiation dose to achieve differing image quality requirements,
and CT examinations were divided based on clinical indications
into stand-alone low, routine, or high dose categories (Table 1).
The approach to determining low, routine, or high radiation
doses within these categories was informed by the following: (a)
a review of the published literature; (b) consultation with radiologists with specialty expertise; (c) input from a technical expert
panel assembled in relation to the creation of a CT quality measure for the Centers for Medicare and Medicaid Services; and
(d) empirical evaluation of 4.5 million consecutive CT examinations, described herein (14).
We constructed the CT categories based on perceived image quality requirements, which have face validity as assessed by
the technical expert panel (14). For example, the image quality required to observe a small, well-defined structure such as
a lung nodule surrounded by air is less than the quality needed
to study the margins of a mass adjacent to other organs when
assessing the extent of a lung cancer. Thus, these indications are
included in different CT categories—low dose chest and routine
dose chest, respectively. There were no direct image quality assessments made as part of this research.
The emphasis in creating the CT categories was to identify indications that were exceptions to the routine dose
radiology.rsna.org n Radiology: Volume 000: Number 0—Month 2021
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Table 1: Indications Associated with Low, Routine, and High Radiation Dose CT Categories for Head, Chest, Cardiac, and
Abdomen Imaging

Radiation
Dose Level

Indications for
Head Imaging

Indications for
Chest Imaging

Indications for
Cardiac Imaging

Indications for
Abdomen Imaging

Low dose

Lung cancer screening; lung Coronary calcium scoring Colon cancer screening; renal stones
nodule surveillance
(known or suspected); bladder (without
contrast material)
Angiography, coronary
Abscess; angiography; gastrointestinal
Angiography; cancer;*
tract evaluation, enterography;† liver
interstitial lung disease;
pulmonary embolism;
(not otherwise specified); trauma
trauma; high resolution
Perfusion angiography Dissection
Transcatheter aortic valve Abdominal run-off; acute gastrointestinal
replacement
bleeding; adrenal nodule; angiography
for aortic injury;‡ biliary cancer;
bladder cystography (with contrast
material); fistula; hepatocellular cancer;
metastatic cancer;§ pancreas (pancreatic
cancer); renal mass (hematuria or
cancer); transplant (donor, recipient, or
postoperative); urography

Facial skeleton;
sinus; bone;
ventricular shunt
Routine dose Suspected
hemorrhage
(stroke); trauma
High dose

Note.—These listed diagnoses are usually suspected, not confirmed, at the time of imaging.
* Cancer includes evaluation for suspected cancer, staging of known cancer, and evaluation for suspected metastatic disease.
†
Gastrointestinal tract symptoms include abdominal pain, weight loss, nausea, vomiting, and diarrhea.
‡
Angiography for aortic injury includes assessment for rupture, dissection, and endovascular leak.
§
High radiation dose for abdomen imaging includes evaluation for suspected cancer symptoms, cancer staging, and evaluation for
metastatic disease in the liver, pancreas, biliary system, peritoneum, breast, kidney, adrenal gland, bladder, or unknown primary tumor.

category, rather than to identify every indication for scanning within the routine category. For example, imaging of
facial bones for a suspected fracture would require a lower
radiation dose, whereas imaging of brain tissue to assess perfusion related to a suspected stroke would require a higher
radiation dose, compared with the routine dose head category. The requirement for multiphase scanning was an
important consideration for assigning indications to high
dose categories. Combining the five categories with a single
radiation dose range, the four regions subcategorized as low,
routine, or high dose, and the routine and high dose for
combined head and neck categories resulted in 19 total categories. The body region and clinical indication for each CT
examination in the registry was determined using natural
language processing applied to text strings in the Digital
Imaging and Communications in Medicine metadata, including the study description and protocol name.
The method of using the Digital Imaging and Communications in Medicine metadata to assign CT examinations to the
19 CT categories was validated by comparing this approach to
a determination based on a detailed chart review. Full medical
records, including physician notes, laboratory and pathologic
results, and ordering indication, were abstracted by a radiology
technologist to create the reference standard CT category assignment for a randomly selected sample of 1102 patients who underwent CT at a single health system. The CT category derived
from Digital Imaging and Communications in Medicine metadata was correct for 911 of the 1012 scans (90%).
Radiology: Volume 000: Number 0—Month 2021 n radiology.rsna.org

Radiation Dose
CT scanners report radiation dose metrics derived from acquisition parameters that correlate closely with absorbed dose
and imparted energy, and from which these variables can be
estimated. These scanner-reported metrics are herein referred
to as “radiation dose.” The radiation dose for each CT examination includes all irradiating events that were part of that
examination. Two radiation dose metrics are reported—volume CT dose index (CTDIvol) in milligray and dose-length
product (DLP) in milligray-centimeter. DLP values were
summed across all irradiating events to generate scanninglevel DLP, and CTDIvol was a mean weighted according to
scanning length. All analyses are adjusted for patient size
using the midscanning water-equivalent diameter (15). The
analyses did not adjust for phantom, as CT examinations in
the registry had virtual uniformity in phantom selection by
body region. The diagnostic reference level (DRL) was defined as the 75th percentile of the observed distribution of
size-adjusted CTDIvol and DLP.
Statistical Analysis
For each CT category, the scanning frequency and the median
and DRL in radiation dose for CTDIvol and DLP were calculated. For the head, chest, cardiac, and abdomen categories, we
compared mean doses between low and high dose categories
using analysis of variance and estimated ratios of the median
radiation doses, with 95% CIs, after adjusting for patient size.
P , .05 was considered a statistically significant difference.
3
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For each indication within the head, chest, abdomen, and cardiac low, routine, and high dose
categories, the CTDIvol versus DLP was graphed
showing 25th, 50th, and 75th percentiles. Two sets
of analysis of variance analyses were conducted with
size-adjusted DLP as the outcome variable. Analysis
of variance uses F tests to statistically test the equality of means. The F statistic is a ratio of two variances (ie, a measure of dispersion). First, we assessed
whether the radiation dose varied according to clinical indications within each category. A finding that
radiation doses were strongly associated with clinical
indications within a category would suggest that the
determination of indication for each examination
was accurate. Second, we compared the variation
in radiation doses within a category (eg, low dose
head) with the variation in doses across categories
within the same body region (eg, low, routine, and
high dose head). A finding of greater variation across
categories within a body region than that within the
categories of that body region would suggest the assignment of clinical indications to the low, routine,
or high dose category is appropriate. R software
(version 3.6.3, R Foundation for Statistical Computing) was used for all analyses.

Results
Approximately 4.5 million CT examinations were
included (Table 2). Overall, 80.9% of the examinations (3 671 128) were from the United States.
The 19 categories capture approximately 91.0% of
CT examinations (4 129 165) in the registry during the testing period. The number of CT examinations performed for each age group increased
with age up to 70 years. The body regions of head,
chest, and abdomen comprised 71.9% (3 266 546)
of total CT examinations. Within these three body
regions, the routine category accounted for 67% of
examinations (2 796 365) (83.4% of head examinations [1 040 518], 94.8% of chest examinations
[753 583], and 86.2% of abdominal examinations
[1 002 264]). As a result, around six in 10 CT examinations were in the categories of routine dose
abdomen, routine dose head, or routine dose chest
(Table 3). The median and DRL for DLP and CTDIvol were significantly different across the 19 categories (P , .001 for all analysis of variance values).
DLP Findings
Next, we assessed the DLP and CTDIvol to determine whether there were differences in radiation
doses across different CT categories. Within the
head, chest, abdomen, and cardiac body regions, the
median and DRL radiation doses for DLP were significantly different across the low, routine, and high
dose categories (P , .001 for all) (Table 3, Fig 1). For

4

Table 2: Characteristics of Included Patients and CT Examinations

No. of CT Examinations
(n = 4 537 341)

Characteristic
Time period
January 1, 2016–December 31, 2016
January 1, 2017–December 31, 2017
January 1, 2018–December 31, 2018
January 1, 2019–December 31, 2019
Missing
Country
Germany
Israel
Japan
Netherlands
Switzerland
United Kingdom
United States
Missing
Age (y)
18–29
30–39
40–49
50–59
60–69
70–79
80–89
90 and older
Missing
Sex
F
M
Other
Unknown
Missing
Scanner manufacturer
Canon
General Electric
Philips
Siemens
Missing
Body region
Head
Neck
Chest
Cardiac
Abdomen
Thoracolumbar spine
Extremity
Combined chest and abdomen
Combined head and neck
Combined thoracolumbar spine
Missing, unidentified, or other combined
body regions

1 265 334 (27.9)
1 259 131 (27.8)
1 131 946 (24.9)
853 398 (18.8)
27 532 (0.6)
112 956 (2.5)
318 293 (7.0)
92 845 (2.0)
88 321 (1.9)
116 594 (2.6)
109 672 (2.4)
3 671 128 (80.9)
27 532 (0.6)
351 104 (7.8)
385 733 (8.6)
527 455 (11.7)
806 853 (17.9)
956 631 (21.2)
802 601 (17.8)
476 108 (10.6)
203 324 (4.5)
35 989 (0.8)
2 316 913 (51.4)
2 152 643 (47.9)
29 140 (0.6)
2656 (,0.1)
27 532 (0.6)
414 408 (9.1)
1 900 558 (41.9)
874 142 (19.3)
1 294 716 (28.5)
53 517 (1.2)
1 243 712 (27.4)
262 037 (5.8)
798 780 (17.6)
60 381 (1.3)
1 163 673 (25.6)
141 043 (3.1)
96 548 (2.1)
260 090 (5.7)
98 184 (2.2)
4717 (0.1)
408 176 (9.0)

Note.—Data are numbers of examinations, with percentages in parentheses.
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Table 3: Frequency of CT Categories and 50th and 75th Percentiles in DLP and CTDIvol Values of Radiation Dose for Each Category

50th Percentile in
Radiation Dose
for DLP
No. of
Location and Dose Examinations
Head
Low dose
Routine dose
High dose
Chest
Low dose
Routine dose
High dose
Abdomen
Low dose
Routine dose
High dose
Cardiac
Low dose
Routine dose
High dose
Location
Neck
Thoracolumbar
spine
Extremity
Combination
Chest and
abdomen
Head and neck
routine
Head and neck
high
Thoracolumbar
spine

Dose
(mGy · Relative
cm)
Dose*

75th Percentile in
Radiation Dose
for DLP
Dose
(mGy · Relative
cm)
Dose*

50th Percentile in
Radiation Dose
for CTDIvol

75th Percentile in
Radiation Dose
for CTDIvol

Dose
Dose
(mGy ·
(mGy · Relative
cm)
Relative Dose* cm)
Dose*

143 093 (3.5)
375
1 040 518 (25.2) 852
60 101 (1.5) 1280

NA
NA
3.4 (3.4, 3.5)

622
1050
1866

NA
NA
3.0 (3.0, 3.0)

20
45
94

NA
31
NA
55
4.8 (4.8, 4.87) 150

NA
NA
4.8 (4.7, 4.8)

43 202 (1.0)
85
753 583 (18.3) 347
1995 (.0.1) 813

NA
NA
9.6 (9.3, 10.0)

111
556
1243

NA
NA
11.2 (10.8, 11.7)

2
9
12

NA
NA
4.9 (4.7, 5.1)

3
13
17

NA
NA
5.5 (5.3, 5.6)

77 464 (1.9)
508
1 002 264 (24.3) 657
83 945 (2.0) 1237

NA
NA
2.4 (2.4, 2.5)

768
1063
1926

NA
2.5 (2.5, 2.5)

9
11
10

NA
NA
1.1 (1.1, 1.2)

14
17
15

NA
NA
1.1 (1.1, 1.1)

NA
112
NA
743
18.1 (17.7, 18.6) 2217

NA
NA
19.8 (19.1, 20.4)

6
11
24

NA
NA
4.0 (3.8, 4.2)

7
23
54

NA
NA
6.2 (6.1, 6.3)

17 164 (0.4)
39 031 (0.9)
4186 (0.1)

82
350
1481

262 037 (6.3)
141 043 (3.4)

409
753

NA
NA

612
1055

NA
NA

16
21

NA
NA

21
30

NA
NA

96 548 (2.3)

299

NA

588

NA

10

NA

18

NA

260 090 (6.3)

768

NA

1261

NA

10

NA

15

NA

88,106 (2.1)

957

NA

1309

NA

21

NA

32

NA

10 078 (0.2)

2547

NA

3646

NA

145

NA

25

NA

4 717 (0.1)

807

NA

1234

NA

16

NA

20

NA

Note.—Except where indicated, data are numbers of examinations, with percentages in parentheses. P , .001 for all. For head, chest,
abdomen, and cardiac, relative radiation dose and 95% CIs for the high dose versus low dose category are provided. Fiftieth percentile is
the median, and 75th percentile is the diagnostic reference level. Examinations with unknown CT categories (ie, missing, unidentified, or
other combined body regions) were not included in this Table. CTDIvol = volume CT dose index, DLP = dose-length product, NA = not
applicable.
* Numbers in parentheses are 95% CIs.

example, for head, the median DLP was 375 mGy · cm for
low dose, 852 mGy · cm for routine dose, and 1280 mGy ·
cm for high dose (difference between categories, P , .001).
Within these body regions, the relative radiation doses between
the high dose versus low dose categories were significantly different, which suggests the assignment of the indications to the
low, routine, and high dose categories was appropriate, thus
validating the categories. For median DLP, these ratios were
3.4 (95% CI: 3.4, 3.5) for head; 9.6 (95% CI: 9.3, 10.0) for
chest; 2.4 (95% CI: 2.4, 2.5) for abdomen; and 18.1 (95% CI:
17.7, 18.6) for cardiac (all P , .001). For DRL DLP, these
ratios were similar. Taken together, the finding of large differ-

Radiology: Volume 000: Number 0—Month 2021 n radiology.rsna.org

ences in radiation doses across the different categories suggests
that the assignment of specific clinical indications to each category is appropriate.
CTDIvol Findings
As with DLP, the median and DRL CTDIvol were higher within
each body region for the high dose compared with the low dose
categories (Table 3, Fig 1). For example, for head CT, the median CTDIvol was 20 mGy for low dose, 45 mGy for routine
dose, and 94 mGy for high dose (difference between categories,
P , .001). The ratio of median radiation doses using CTDIvol
was 4.8 (95% CI: 4.8, 4.8) for head; 4.9 (95% CI: 4.7, 5.1) for

5
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Figure 1: Box plots show distribution of dose-length product (DLP) and volume CT dose index (CTDIvol) for each CT category.
Box edges indicate 25th and 75th percentiles. Thick vertical line indicates median. C = cervical, L = lumbar, T = thoracic.

chest; 1.1 (95% CI: 1.1, 1.2) for abdomen; and 4.0 (95% CI:
3.8, 4.2) for cardiac.
Clinical Indications
CTDIvol and DLP associated with specific indications that contributed to the head, chest, abdomen, and cardiac CT categories
are shown in Table 4, and the CTDIvol and DLP of each indication are shown in Figure 2. Head, chest, and cardiac imaging
had relatively clear separation in DLP across the subcategories
(Fig 2). Abdominal imaging showed more overlap between subcategories. Taken together, although these four body regions exhibit variation in radiation doses based on clinical indications
within each CT category (Tables 4, 5), the variation was far
greater between CT categories than within categories (Figure 2).

Discussion
We described a framework to assign diagnostic CT examinations into broad categories based on a combination of body
region and clinical indications. The distribution of study types,
in particular those of the head, chest, and abdomen, is similar
to the recent U.S. National Council on Radiation Protection
and Measurements Report 184 (12). Within the head, chest,
abdomen, and cardiac body regions, the median and diagnostic
6

reference level radiation doses for volume CT dose index (CTDIvol) and dose-length product (DLP) were significantly different across the low, routine, and high dose categories. The larger
differences in CTDIvol and DLP between categories in comparison to within categories validates the 19 categories. The
proposed 19 categories offer a simplified and valid alternative
for assessing radiation dose in comparison to protocol-specific
benchmarking widely in use (1). The finding of large differences in both CTDIvol and DLP across the different categories
suggests that the assignment of specific clinical indications to
each category is appropriate. We found larger differences between categories within body regions using DLP than in those
using CTDIvol. This was expected, as the indications were categorized according to the total expected radiation dose and not
according to the average dose per rotation. For many high dose
categories, the higher dose is the result of multiphase scanning
rather than a higher dose per rotation.
The purpose of this framework is not to provide benchmark
doses according to indication or category, but it may yield guidance for standardizing protocols, assigning patients to the appropriate protocol, and assessing whether a facility’s radiation doses
are appropriate relative to image quality requirements. Three categories—routine dose head (1 040 518 examinations), routine
radiology.rsna.org n Radiology: Volume 000: Number 0—Month 2021
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Table 4: Median, 25th, and 75th Percentiles of DLP and CTDIvol for Each Clinical Indication for Head, Chest, Cardiac, Abdomen,
and Combined Head and Neck Body Regions

CT Category and Indication
Head
Low dose
  Sinus
   Temporal bone
   Ventricular shunt
  Facial skeleton
Routine dose
  Stroke
   Head, routine or not otherwise specified
  Trauma
High dose
  Perfusion angiography
Chest
Low dose
   Lung cancer screening and nodule surveillance
Routine dose
   Chest, routine or not otherwise specified
  Pulmonary embolism
  High resolution
   Angiography
   Interstitial lung disease
  Trauma
  Lung cancer
High dose
  Dissection
Cardiac
Low dose
  Coronary calcification
Routine dose
   Cardiac, routine, or not otherwise specified
  Coronary angiography
High dose
Transaortic valvular replacement
Abdomen
Low dose
  Colonography
   Suspected renal stones
   Bladder (without contrast material)
Routine dose
  Abscess
   Abdomen routine, not otherwise specified
   Gastrointestinal tract evaluation, enterography
  Trauma
  Angiography
   Liver, not otherwise specified
High dose
  Adrenal nodule
  Fistula
   Angiography for aortic injury†
  Transplant
   Bladder with contrast
  Pancreas
   Hepatocellular and biliary cancers

No. of Examinations

CTDIvol*

DLP*

55 190
13 628
30
74 245

17 (11–22)
38 (29–55)
18 (18–18)
21 (14–32)

262 (167–383)
417 (293–595)
386 (368–408)
531 (310–716)

23 026
970 080
47 412

46 (42–53)
45 (37–55)
45 (40–52)

891 (778–1066)
851 (688–1048)
851 (761–1085)

60 101

94 (55–150)

1280 (751–1866)

43 202

2 (2–3)

85 (62–111)

492 726
93 648
26 718
126 363
2690
9726
1712

8 (5–12)
10 (6–15)
9 (6–13)
11 (8–16)
7 (4–9)
15 (10–0)
2 (2–7)

303 (176–504)
373 (236–565)
428 (292–601)
441 (293–712)
545 (318–759)
657 (474–980)
69 (55–336)

1995

12 (8–17)

813 (574–1243)

17 164

6 (4–8)

82 (56–112)

12 125
26 906

7 (3–16)
13 (7–25)

220 (74–499)
417 (191, 903)

4186

24 (14–47)

1481 (898–2217)

9933
49 233
18 130

4 (3–5)
9 (6–15)
11 (7–14)

429 (298–532)
493 (323–797)
614 (396–790)

302
884 106
29 846
19 518
36 705
25 016

11 (7–17)
11 (8–17)
10 (7–15)
15 (10–21)
11 (7–15)
10 (7–16)

444 (268–766)
640 (412–1022)
517 (354–864)
833 (517–1405)
1117 (675–1801)
1151 (600–2007)

353
54
8220
2832
4993
9702
6595

12 (9–15)
9 (6–13)
7 (4–12)
7 (6–10)
10 (6–15)
11 (8–16)
9 (6–14)

397 (227–684)
615 (464–910)
667 (365–1240)
704 (468–1086)
1187 (544–2014)
1171 (753–1777)
1276 (824–2024)
Table 4 (continues)
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Table 4: (continued) Median, 25th, and 75th Percentiles of DLP and CTDIvol for Each Clinical Indication for Head, Chest, Cardiac,
Abdomen, and Combined Head and Neck Body Regions

CT Category and Indication

No. of Examinations

  Metastatic cancers
2827
  Urography
32 287
   Acute gastrointestinal bleeding
3560
  Abdominal run-off
10 025
  Renal mass
9436
Combined head and neck
Routine dose
   Routine dose head combined with any neck and/or cervical spine 88 106
High dose
   High dose head combined with any neck and/or cervical spine
10 078

CTDIvol*

DLP*

15 (10–20)
11 (8–16)
10 (7–15)
8 (6–11)
14 (10–19)

1074 (811–1411)
1144 (710–1817)
1310 (834–2060)
1386 (991–2147)
1633 (1069–2337)

21 (14–32)

957 (580–1309)

145 (99–262)

2547 (1676–3646)

Note.—CTDIvol = volume CT dose index, DLP = dose-length product.
* Numbers are medians, with interquartile ranges (25th and 75th percentiles) in parentheses.
†
Angiography for aortic injury includes rupture, dissection, and endovascular leak.

For the purpose of comparing
radiation doses across facilities,
assessing doses within broad CT
categories based on clinical indication is more informative than
assessing doses within protocols.
Dose assessment within protocol
groups ignores the primary factor determining dose (ie, protocol selection), which is almost
entirely at the discretion of the
radiologist. Assessing doses in
this way, without considering
the underlying indication, ignores the variation that occurs
due to protocol choice and fails
to identify patients who require
a particular protocol, such as
single-phase abdomen, but who
instead received much higher
doses through unnecessary multiphase examinations. Radiation
doses should be assessed based
on the intent and clinical question of the provider ordering the
Figure 2: Graphs show volume CT dose index (CTDIvol) and dose-length product (DLP) for each indication that comexamination, not on the radioloprises (A) head, (B) chest, (C) abdomen, and (D) cardiac CT categories. Length of arms in cross show interquartile range
gist’s choice of protocol.
in radiation dose. Intersection of arms is median for CTDIvol and DLP, number of lines reflects number of indications in catThe data for this study were
egory, and line thickness is proportional to number of examinations in category. For each indication, CTDIvol is defined as
pulled
from the University of
mean CTDIvol across all irradiating events weighted by scanning length, and DLP value is summation across all irradiating
California
San Francisco regisevents. For example, in three-phase study, where each phase (ie, irradiating event) had average CTDIvol of 10 mGy, scanning length of 50 cm, and DLP of 500 mGy · cm, study would be shown in plot as average weighted CTDIvol of 10 mGy
try, but other data sources, such
and total DLP of 1500 mGy · cm.
as the larger American College
of Radiology Dose Index Regisdose chest (753 583 examinations), and routine dose abdomen
try, could be used to similarly categorize CT examinations based
(1 002 264 examinations)—accounted for 62% of all CT examion the indications that led to the examinations and then to crenations. Given this frequency, optimizing acquisition protocols
ate radiation dose benchmarks for those categories (12). Because
in these three categories alone could have a substantial impact
the existing American College of Radiology benchmarks are creon reducing overall radiation exposure from CT examinations.
ated according to protocol (1), rather than according to clinical
8
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Table 5: Variation within Indications versus between Indications for CT Categories and within Categories versus between
Categories within Body Regions

Variation between Indications within CT Category

Location
and Dose
Head
Low dose
Routine dose
High dose*
Chest
Low dose*
Routine dose
High dose*
Abdomen
Low dose
Routine dose
High dose
Cardiac
Low dose*
Routine dose
High dose*

Mean Square
Mean Square between Indication
within CT
within
Category
Indications

Between
versus
Within
(F value)

Ratio of
F Value
to N

142 076
121 079
NC

633 014 914
127 912 884
NC

4455
1056
NC

0.04
0.00
NC

NC
162 960
NC

NC
618 213 847
NC

NC
3794
NC

NC
0.01
NC

107 303
260 005
738 482

54 353 482
1 082 879 111
385 328 496

507
4165
522

0.01
0.00
0.01

NC
315 257
NC

NC
482 266 188
NC

NC
1530
NC

NC
0.05
NC

Variation between CT Categories
Mean Square
Mean Square between CT
Categories within
within CT
Body Region
Category

Between
versus
Within
(F value)

Ratio
of F
Value
to N

175 236

16 976 982 486

96 881

0.10

161 216

2 451 443 505

15 206

0.02

308 649

14 395 193 179

46 639

0.05

316 698

3 997 851 468

13 342

0.26

Note.—P , .001 for all statistical comparisons. N = number of examinations, NC = not calculated.
* Each of these CT categories had only one indication; thus, these values were NC.

indication as described herein, it is not possible to directly compare observed doses. However, given the similarity in how CT
examinations are assembled in the University of California San
Francisco and American College of Radiology registries, it would
be worthwhile to compare benchmarks based on indications
across the registries.
For some CT categories, the observed doses reflect
optimized levels. For example, the median CTDIvol for
low dose chest is 2 mGy, consistent with the American
College of Radiology benchmarks (16). For other categories, the observed doses are not optimized. For example, for abdomen low dose, where 64% of examinations assessed renal calculi, the median in CTDIvol
was 9 mGy, higher than the optimum of less than 4 mGy
(17). The consistency in doses for CT examinations performed for lung cancer screening with American College of
Radiology benchmarks may be driven by the fact that reporting is required by the Centers for Medicare and Medicaid Services for reimbursement. The inconsistency in doses
for suspected renal stone imaging is consistent with previously reported deviation between observed and optimum
practice (9,18). Although the proposed framework does
not provide optimized dose levels because actual practice is
often not optimized, adoption of this simplified approach
for assessing radiation doses may nevertheless contribute to
dose improvement over time by allowing consistent measurement of current practice.
A potential application of the framework is in meeting
standards of regulators and accreditors. For example, the Joint
Radiology: Volume 000: Number 0—Month 2021 n radiology.rsna.org

Commission requires that hospitals ensure patients receive appropriate imaging based on their clinical indication for scanning
and review of incidents in which the radiation dose delivered
exceeds the expected dose for that protocol (19). This standard
requires hospitals to have a system to both assign patients to
protocols and to generate radiation dose thresholds for each
protocol; however, there is no consistent standard used across
hospitals. We believe that our approach could provide a simpler
and more effective solution for comparing radiation doses across
institutions, leading to dose optimization and ultimately a reduction in excessively high radiation doses.
This study’s main strengths include its large sample size and
inclusion of the majority of CT examinations from diverse imaging facilities. The study had several limitations. First, a large
number of CT examinations in the registry were for “routine”
purposes and where indication was not specified. However, because our primary aim was to identify examinations that required radiation doses that were not routine (ie, high or low),
the inability to identify a precise indication for examinations
considered routine does not undermine the approach. If there
were multiple clinical indications for CT, the examination was
assigned to the higher dose category. Although this may have
added imprecision, excluding such examinations would have
inflated the differences between groups; thus, their inclusion
was conservative.
Nearly all diagnostic CT examinations in the present study
can be assigned to one of the identified categories. Nonetheless,
facilities may need to create additional protocols if they have patients with unique needs not captured in the indications that
9
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we observed. The categories were created in part based on expert opinion and face validity rather than on evidence associated
with diagnostic accuracy; thus, additional research is needed to
determine the minimum required image quality for diagnostic
accuracy for each indication. As the framework is applied, refinements might include combining or subdividing some of the 19
categories. The assignment of examinations to the CT categories based on Digital Imaging and Communications in Medicine metadata has inaccuracies; 408 176 examinations (approximately 10%) were misclassified in our assessment. The accuracy
of assigning examinations to CT categories based on clinical indication may be improved using information extracted from the
electronic health record associated with the study order. Finally,
sites contributing to the registry use a single-dose management
software, which could introduce bias if sites that use such monitoring programs pay closer attention to radiation use.
Based on the large data set of the University of California San
Francisco International CT Dose Registry, we established a framework to assess radiation doses. These categories may offer imaging
facilities a consistent, simplified approach to radiation dose assessment, optimization, and reduction of unintended harm.
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